Nilotinib for the treatment of chronic myeloid leukemia: An evidence-based review

por Jabbour, Elias, Cortes, Jorge, Kantarjian, Hagop
Publicado 2010

Gilteritinib in the treatment of relapsed and refractory acute myeloid leukemia with a FLT3 mutation

por Chew, Serena, Mackey, Melissa C., Jabbour, Elias
Publicado 2020

Sudden Cardiopulmonary Collapse in a Patient With Coronavirus Disease 2019

por Jabbour, Elias, Malik, Danish, Shiloh, Ariel L.
Publicado 2021

Development and targeted use of nilotinib in chronic myeloid leukemia

por Fava, Carmen, Kantarjian, Hagop, Cortes, Jorge, Jabbour, Elias
Publicado 2009

Evaluation and management of measurable residual disease in acute lymphoblastic leukemia

por Abou Dalle, Iman, Jabbour, Elias, Short, Nicholas J.
Publicado 2020

Cancer and COVID-19

por Malek, Alexandre E, Raad, Issam I, Jabbour, Elias
Publicado 2020

Clinical Value of Measurable Residual Disease in Acute Lymphoblastic Leukemia

por Hein, Kyaw, Short, Nicholas, Jabbour, Elias, Yilmaz, Musa
Publicado 2022

Suboptimal Responses in Chronic Myeloid Leukemia

por Jabbour, Elias, Saglio, Giuseppe, Hughes, Timothy P, Kantarjian, Hagop
Publicado 2012

Concepts in immuno-oncology: tackling B cell malignancies with CD19-directed bispecific T cell engager therapies

por Viardot, Andreas, Locatelli, Franco, Stieglmaier, Julia, Zaman, Faraz, Jabbour, Elias
Publicado 2020

Chimeric antigen receptor T-cell therapy for adult B-cell acute lymphoblastic leukemia: state-of-the-(C)ART and the road ahead

por Pasvolsky, Oren, Kebriaei, Partow, Shah, Bijal D., Jabbour, Elias, Jain, Nitin
Publicado 2023

Evolving therapy of adult acute lymphoblastic leukemia: state-of-the-art treatment and future directions

por Samra, Bachar, Jabbour, Elias, Ravandi, Farhad, Kantarjian, Hagop, Short, Nicholas J.
Publicado 2020

Eine klinische Perspektive auf die Behandlung von chronischer myeloischer Leukämie in der chronischen Phase

por García-Gutiérrez, Valentin, Breccia, Massimo, Jabbour, Elias, Mauro, Michael, Cortes, Jorge E.
Publicado 2023

A clinician perspective on the treatment of chronic myeloid leukemia in the chronic phase

por García-Gutiérrez, Valentin, Breccia, Massimo, Jabbour, Elias, Mauro, Michael, Cortes, Jorge E.
Publicado 2022

Novel monoclonal antibody-based treatment strategies in adults with acute lymphoblastic leukemia

por Guerra, Veronica A., Jabbour, Elias J., Ravandi, Farhad, Kantarjian, Hagop, Short, Nicholas J.
Publicado 2019

Inotuzumab ozogamicin for the treatment of acute lymphoblastic leukemia

por Savoy, J. Michael, Welch, Mary Alma, Nasnas, Patrice E., Kantarjian, Hagop, Jabbour, Elias
Publicado 2018

Gastric Myeloid Sarcoma

por Shaikh, Abdullah S., Almanza Huante, Emmanuel, Taherian, Mehran, Quesada, Andres E., Jabbour, Elias J., Thirumurthi, Selvi
Publicado 2023

The evolution of acute lymphoblastic leukemia research and therapy at MD Anderson over four decades

por Jabbour, Elias, Short, Nicholas J., Jain, Nitin, Haddad, Fadi G., Welch, Mary Alma, Ravandi, Farhad, Kantarjian, Hagop
Publicado 2023

Management of chronic myeloid leukemia in 2023 – common ground and common sense

por Senapati, Jayastu, Sasaki, Koji, Issa, Ghayas C., Lipton, Jeffrey H., Radich, Jerald P., Jabbour, Elias, Kantarjian, Hagop M.
Publicado 2023

P687: EARLY RESULTS OF A PHASE II STUDY EVALUATING THE ADDITION OF ASCIMINIB TO ERADICATE MINIMAL RESIDUAL DISEASE IN CHRONIC MYELOID LEUKEMIA

por Bidikian, Aram, Short, Nicholas, Ganesh, Ramya, Pike, Allison, Sasaki, Koji, Jabbour, Elias, Andreeff, Michael, Cortes, Jorge, Issa, Ghayas
Publicado 2023

AML-343: Loss of H3K27 Methylation Identifies Poor Outcomes in Adult-Onset Acute Lymphoblastic and Myeloid Leukemia

por Dijk, Anneke van, Hoff, Fieke, Qiu, Yihua, Jabbour, Elias, Bont, Eveline de, Bruggeman, Sophia, Horton, Terzah, Kornblau, Steven
Publicado 2020